Trump, Hims and Marty Makary

Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink ...
After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.
Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug ...
Mr. Trump nominated Marty Makary, MD, on Nov. 22 to head the FDA ... Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg ...
Here's what's taking off and landing in the world of Bay Area business this Tuesday morning. Don't be let down.
Makary, a professor at Johns Hopkins University, is the latest in a string of Trump nominees who have declared the U.S. health system “broken," vowing a shakeup. As part of a flurry of ...